Published in Int J Clin Exp Pathol on July 01, 2015
Estimating the world cancer burden: Globocan 2000. Int J Cancer (2001) 16.92
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet (1981) 13.54
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer (1988) 7.05
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife (2012) 5.18
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer (2009) 3.52
WNT/beta-catenin signaling in liver health and disease. Hepatology (2007) 3.26
Hepatocellular carcinoma. J Hepatol (2000) 2.77
The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol (2002) 2.47
Hippo pathway activity influences liver cell fate. Cell (2014) 2.24
HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol (2011) 2.10
HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol (1997) 1.98
Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res (2001) 1.58
Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer (2007) 1.55
Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer (2007) 1.54
Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J Biol Chem (2004) 1.53
Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res (2003) 1.51
Opportunities for targeted therapies in hepatocellular carcinoma. J Clin Oncol (2005) 1.45
Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers (2011) 1.36
HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6. Cancer Res (2007) 1.33
Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J Virol (2000) 1.28
Cyclin D1 overexpression in hepatocellular carcinoma. Liver (2001) 1.14
HAX-1 overexpression, splicing and cellular localization in tumors. BMC Cancer (2010) 1.11
Biomarkers for hepatocellular carcinoma. Int J Hepatol (2012) 1.00
Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition. J Virol (2009) 0.92
Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Exp Mol Pathol (2009) 0.92
P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection. Liver Int (2007) 0.91
Expression of HAX-1 in human colorectal cancer and its clinical significance. Tumour Biol (2013) 0.86